{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T15:17:40Z","timestamp":1775056660348,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"DOI":"10.1007\/s00192-026-06579-7","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T13:40:28Z","timestamp":1775050828000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of Platelet-Rich Plasma in Interstitial Cystitis\/Bladder Pain Syndrome: A Systematic Review and Meta-Analysis"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0942-8658","authenticated-orcid":false,"given":"Fawad","family":"Ali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7942-4062","authenticated-orcid":false,"given":"Abdul","family":"Haseeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1159-7124","authenticated-orcid":false,"given":"Hira Bakhtiar","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2661-8697","authenticated-orcid":false,"given":"Muhammad","family":"Maaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waleed","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"issue":"1","key":"6579_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12010075","volume":"12","author":"HY Lin","year":"2021","unstructured":"Lin HY, Lu JH, Chuang SM, Chueh KS, Juan TJ, Liu YC, et al. Urinary biomarkers in interstitial cystitis\/bladder pain syndrome and its impact on therapeutic outcome. Diagnostics. 2021;12(1):75.","journal-title":"Diagnostics"},{"issue":"23","key":"6579_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232314594","volume":"23","author":"J Li","year":"2022","unstructured":"Li J, Yi X, Ai J. Broaden horizons: the advancement of interstitial cystitis\/bladder pain syndrome. Int J Mol Sci. 2022;23(23):14594.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"6579_CR3","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.juro.2011.03.132","volume":"186","author":"SH Berry","year":"2011","unstructured":"Berry SH, Elliott MN, Suttorp M, Bogart LM, Stoto MA, Eggers P, et al. Prevalence of symptoms of bladder pain syndrome\/interstitial cystitis among adult females in the United States. J Urol. 2011;186(2):540\u20134.","journal-title":"J Urol"},{"issue":"7","key":"6579_CR4","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/iju.14234","volume":"27","author":"Y Homma","year":"2020","unstructured":"Homma Y, Akiyama Y, Tomoe H, Furuta A, Ueda T, Maeda D, et al. Clinical guidelines for interstitial cystitis\/bladder pain syndrome. Int J Urol. 2020;27(7):578\u201389.","journal-title":"Int J Urol"},{"key":"6579_CR5","first-page":"273","volume":"31","author":"L Cacciatore","year":"2024","unstructured":"Cacciatore L, Territo A, Minore A, Testa A, Mantica G, Esperto F. Bladder pain syndrome (BPS): a comprehensive review of treatment strategies and management approaches. Res Rep Urol. 2024;31:273\u201382.","journal-title":"Res Rep Urol"},{"issue":"2","key":"6579_CR6","doi-asserted-by":"publisher","first-page":"113","DOI":"10.5489\/cuaj.10095","volume":"5","author":"AA Al-Zahrani","year":"2011","unstructured":"Al-Zahrani AA, Gajewski JB. Long-term efficacy and tolerability of pentosan polysulphate sodium in the treatment of bladder pain syndrome. Can Urol Assoc J. 2011;5(2):113\u20138.","journal-title":"Can Urol Assoc J"},{"issue":"1","key":"6579_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-72292-0","volume":"10","author":"YH Jiang","year":"2020","unstructured":"Jiang YH, Kuo YC, Jhang JF, Lee CL, Hsu YH, Ho HC, et al. Repeated intravesical injections of platelet-rich plasma improve symptoms and alter urinary functional proteins in patients with refractory interstitial cystitis. Sci Rep. 2020;10(1):15218.","journal-title":"Sci Rep"},{"key":"6579_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.853776","volume":"13","author":"YH Jiang","year":"2022","unstructured":"Jiang YH, Jhang JF, Lin TY, Ho HC, Hsu YH, Kuo HC. Therapeutic efficacy of intravesical platelet-rich plasma injections for interstitial cystitis\/bladder pain syndrome\u2014a comparative study of different injection number, additives and concentrations. Front Pharmacol. 2022;13:853776.","journal-title":"Front Pharmacol"},{"issue":"5","key":"6579_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10051182","volume":"10","author":"YK Lee","year":"2022","unstructured":"Lee YK, Jiang YH, Jhang JF, Ho HC, Kuo HC. Changes in the ultrastructure of the bladder urothelium in patients with interstitial cystitis after intravesical injections of platelet-rich plasma. Biomedicines. 2022;10(5):1182.","journal-title":"Biomedicines"},{"issue":"3","key":"6579_CR10","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1002\/nau.23421","volume":"37","author":"LC McKernan","year":"2018","unstructured":"McKernan LC, Walsh CG, Reynolds WS, Crofford LJ, Dmochowski RR, Williams DA. Psychosocial co-morbidities in interstitial cystitis\/bladder pain syndrome (IC\/BPS): a systematic review. Neurourol Urodyn. 2018;37(3):926\u201341.","journal-title":"Neurourol Urodyn"},{"issue":"6","key":"6579_CR11","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1016\/j.juro.2009.02.030","volume":"181","author":"JC Nickel","year":"2009","unstructured":"Nickel JC, Payne CK, Forrest J, Parsons CL, Wan GJ, Xiao X. The relationship among symptoms, sleep disturbances and quality of life in patients with interstitial cystitis. J Urol. 2009;181(6):2555\u201361.","journal-title":"J Urol"},{"issue":"15","key":"6579_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13154571","volume":"13","author":"E Rahman","year":"2024","unstructured":"Rahman E, Rao P, Abu-Farsakh HN, Thonse C, Ali I, Upton AE, et al. Systematic review of platelet-rich plasma in medical and surgical specialties: quality, evaluation, evidence, and enforcement. J Clin Med. 2024;13(15):4571.","journal-title":"J Clin Med"},{"key":"6579_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n160","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n160.","journal-title":"BMJ"},{"issue":"1","key":"6579_CR14","doi-asserted-by":"publisher","first-page":"72","DOI":"10.4103\/tcmj.tcmj_166_24","volume":"37","author":"WR Yu","year":"2025","unstructured":"Yu WR, Jiang YH, Jhang JF, Kuo HC. Repeated intravesical injections of platelet-rich plasma are safe and effective in the treatment of interstitial cystitis\/bladder pain syndrome. Tzu Chi Med J. 2025;37(1):72\u20139.","journal-title":"Tzu Chi Med J"},{"issue":"1","key":"6579_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25010163","volume":"25","author":"JF Jhang","year":"2023","unstructured":"Jhang JF, Jiang YH, Lin TY, Kuo HC. The tumor necrosis factor-\u03b1 level in platelet-rich plasma might be associated with treatment outcome in patients with interstitial cystitis\/bladder pain syndrome or recurrent urinary tract infection. Int J Mol Sci. 2023;25(1):163.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"6579_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/toxins15020121","volume":"15","author":"JF Jhang","year":"2023","unstructured":"Jhang JF, Yu WR, Kuo HC. Comparison of the clinical efficacy and adverse events between intravesical injections of platelet-rich plasma and botulinum toxin A for the treatment of interstitial cystitis refractory to conventional treatment. Toxins. 2023;15(2):121.","journal-title":"Toxins"},{"issue":"Suppl 1","key":"6579_CR17","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.5213\/inj.2142100.050","volume":"26","author":"JF Jhang","year":"2022","unstructured":"Jhang JF, Jiang YH, Hsu YH, Ho HC, Birder LA, Lin TY, et al. Improved urothelial cell proliferation, cytoskeleton and barrier function protein expression in the patients with interstitial cystitis\/bladder pain syndrome after intravesical platelet-rich plasma injection. Int Neurourol J. 2022;26(Suppl 1):S57\u201367.","journal-title":"Int Neurourol J"},{"issue":"1","key":"6579_CR18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/CU9.0000000000000156","volume":"18","author":"AS El Hefnawy","year":"2024","unstructured":"El Hefnawy AS, Hasan MA, El Sawy E, Abdel-Razik M, El-Tabey N. Intravesical instillation of platelet-rich plasma for treatment of interstitial cystitis\/bladder pain syndrome: a pilot study. Curr Urol. 2024;18(1):49\u201354.","journal-title":"Curr Urol"},{"issue":"10","key":"6579_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10101194","volume":"10","author":"F Trama","year":"2021","unstructured":"Trama F, Illiano E, Marchesi A, Brancorsini S, Crocetto F, Pandolfo SD, et al. Use of intravesical injections of platelet-rich plasma for the treatment of bladder pain syndrome: a comprehensive literature review. Antibiotics. 2021;10(10):1194.","journal-title":"Antibiotics"},{"issue":"2","key":"6579_CR20","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/nau.23898","volume":"38","author":"JF Jhang","year":"2019","unstructured":"Jhang JF, Lin TY, Kuo HC. Intravesical injections of platelet\u2010rich plasma is effective and safe in treatment of interstitial cystitis refractory to conventional treatment\u2014a prospective clinical trial. Neurourol Urodyn. 2019;38(2):703\u20139.","journal-title":"Neurourol Urodyn"},{"key":"6579_CR21","first-page":"1","volume":"25","author":"Y Wu","year":"2025","unstructured":"Wu Y, Chen L, Xu M, Yao L, Yang S, Ang X, et al. Platelet-rich plasma improves cyclophosphamide-induced interstitial cystitis in rat models through the Toll-like receptor 4\/nuclear factor-kappa B signalling pathway. Clin Exp Nephrol. 2025;25:1\u201310.","journal-title":"Clin Exp Nephrol"},{"issue":"1","key":"6579_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-63760-y","volume":"14","author":"AI Abdelgalil","year":"2024","unstructured":"Abdelgalil AI, Yassin AM, Khattab MS, Abdelnaby EA, Marouf SA, Farghali HA, et al. Platelet-rich plasma attenuates the UPEC-induced cystitis via inhibiting MMP-2, 9 activities and downregulation of NGF and VEGF in Canis lupus familiaris model. Sci Rep. 2024;14(1):13612.","journal-title":"Sci Rep"},{"issue":"3","key":"6579_CR23","doi-asserted-by":"publisher","first-page":"211","DOI":"10.5213\/inj.2040104.052","volume":"24","author":"CC Lin","year":"2020","unstructured":"Lin CC, Huang YC, Lee WC, Chuang YC. New frontiers or the treatment of interstitial cystitis\/bladder pain syndrome-focused on stem cells, platelet-rich plasma, and low-energy shock wave. Int Neurourol J. 2020;24(3):211.","journal-title":"Int Neurourol J"},{"issue":"06","key":"6579_CR24","first-page":"609","volume":"16","author":"M Mirzaei","year":"2019","unstructured":"Mirzaei M, Daneshpajooh A, Farsinezhad A, Jafarian Z, Ebadzadeh MR, Saberi N, et al. The therapeutic effect of intravesical instillation of platelet rich plasma on recurrent bacterial cystitis in women: a randomized clinical trial. Urol J. 2019;16(06):609\u201313.","journal-title":"Urol J"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-026-06579-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00192-026-06579-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-026-06579-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T13:40:29Z","timestamp":1775050829000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00192-026-06579-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":24,"alternative-id":["6579"],"URL":"https:\/\/doi.org\/10.1007\/s00192-026-06579-7","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"assertion":[{"value":"6 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no conflicts of interest regarding the publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"This systematic review and meta-analysis used previously published data and did not involve direct interaction with human participants; therefore, Institutional Review Board approval was not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Considerations"}}]}}